Instituto Rosenbusch SA
BCBA:ROSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Instituto Rosenbusch SA
BCBA:ROSE
|
AR |
Intrinsic Value
The intrinsic value of Instituto Rosenbusch SA (ROSE) under the Base Case is 83.93 ARS per share. Compared with the current market price of 148 ARS, the stock appears Overvalued by 43% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 35% in 2024, then slows: about 2% a year on average over the next five years, less than a third of its five-year pace of 58%. Net margin ends at 6.9% by 2031, above its five-year average of -3.1%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Instituto Rosenbusch Does
Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. The company is headquartered in Buenos Aires, Buenos Aires. The company went IPO on 2008-02-21. The firm's products are structured in two lines: Pharmaceutical, including antibiotics, antimastitics products, antimycotics, antiparasites, vitamins, minerals and other chemotherapies, and Biological, comprising vaccines for cattle, equines, porks and sheeps and dogs.
- Headquarters
- Argentina AR
- IPO date
- Feb 21, 2008
Revenue & Expenses Breakdown
Instituto Rosenbusch SA
Earnings Waterfall
Instituto Rosenbusch SA
The intrinsic value for Instituto Rosenbusch SA (ROSE) under the Base Case is 83.93 ARS.
Compared with the current market price of 148 ARS, the stock appears Overvalued by 43% .